BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10187409)

  • 1. Five strategies for managing drug costs under PPS.
    Natl Rep Subacute Care; 1998 Nov; 6(22):4-7. PubMed ID: 10187409
    [No Abstract]   [Full Text] [Related]  

  • 2. A prescription for managing drug costs under PPS.
    Bluemer T
    Contemp Longterm Care; 1999 Mar; 22(3):31. PubMed ID: 10351362
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing medications under PPS.
    Wagner L
    Provider; 1999 Feb; 25(2):24-5, 27-8, 31 passim. PubMed ID: 10345490
    [No Abstract]   [Full Text] [Related]  

  • 4. Opportunities under capital PPS.
    Sutter RN
    Healthc Financ Manage; 1993 Jan; 47(1):76. PubMed ID: 10145741
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financing capital under Medicare--an evaluation.
    Rubin RJ
    Health Syst Rev; 1991; 24(3):33, 35, 37 passim. PubMed ID: 10110623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk contractors take aim at skyrocketing drug costs.
    Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
    [No Abstract]   [Full Text] [Related]  

  • 8. Looking for more time. Providers want longer wait before new PPS starts.
    Lubell J
    Mod Healthc; 2006 Jun; 36(24):8-9. PubMed ID: 16792261
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparing for the inpatient rehabilitation PPS.
    Rielinger JA
    Healthc Financ Manage; 2001 Dec; 55(12):52-5. PubMed ID: 11765633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical risk sharing may cut losses, but is unlikely to produce gain.
    Exec Solut Healthc Manag; 1998 Oct; 1(8):8-10. PubMed ID: 10186111
    [No Abstract]   [Full Text] [Related]  

  • 11. More groups join plea for PPS delay.
    Gardner J
    Mod Healthc; 2000 May; 30(22):3, 11. PubMed ID: 11067159
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimated losses from outpatient PPS rise.
    Hallam K
    Mod Healthc; 1999 May; 29(20):3, 12. PubMed ID: 10387869
    [No Abstract]   [Full Text] [Related]  

  • 13. Reforming the inpatient PPS system.
    Siegel S
    Health Care Law Mon; 2006 Jul; ():3-7. PubMed ID: 16910248
    [No Abstract]   [Full Text] [Related]  

  • 14. Big payment changes ahead? Industry anxiously awaits CMS inpatient PPS ruling.
    Lubell J
    Mod Healthc; 2006 Jul; 36(30):10-1. PubMed ID: 16910089
    [No Abstract]   [Full Text] [Related]  

  • 15. No further PPS adjustments needed--ProPAC.
    Weissenstein E
    Mod Healthc; 1991 Oct; 21(42):10. PubMed ID: 10114213
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of new pharmaceutical agents on pharmacy budgets.
    Kozma CM
    Manag Care Interface; 1999 Jan; 12(1):77-8. PubMed ID: 10345243
    [No Abstract]   [Full Text] [Related]  

  • 17. CMS calls for 2.75 percent FY'03 inpatient PPS increase.
    Hosp Outlook; 2002; 5(3):1, 5. PubMed ID: 12096409
    [No Abstract]   [Full Text] [Related]  

  • 18. Easing the impact. CMS blunts effect of new inpatient PPS.
    Lubell J
    Mod Healthc; 2006 Aug; 36(31):8-9. PubMed ID: 16958345
    [No Abstract]   [Full Text] [Related]  

  • 19. A hospital divided. PPS proposal restricts LTACs in host hospitals.
    Tieman J
    Mod Healthc; 2004 May; 34(20):8-9. PubMed ID: 15164488
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy carve-out offers cost control, computer modeling.
    Capitation Manag Rep; 2002 Jul; 9(7):103-8, 97. PubMed ID: 12164058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.